Gaceta Médica, leading newspaper in health information, interviews Dra. Isabel Portero, CEO & Founder of BIOHOPE

"Closer to the personalization of renal transplant treatment. First study to evaluate the functionality of the immunobiogram to predict the immunosuppressive response." > Read  More

2018-07-27T11:17:11+00:00July 26th, 2018|Clinical Development, Research|0 Comments

Different media publish the new of the success of the immunobiogram

Following the presentation of Biohope at the Congress of the International Society of Transplantation held in Madrid, the media have published different articles on the results of the clinical study that demonstrate the usefulness of the Immunobiogram. Diario medico 'Antibiogram of immunity' for rejection in kidney graft" >Read Article (pdf) Diario Médico.com > Read Article [...]

2018-07-18T16:06:22+00:00July 15th, 2018|Clinical Development, Research|0 Comments

BIOHOPE WILL EXPLAIN THE PROMISING DATA FROM PILOT STUDY TO THEIR SCIENTIFIC ADVISORY BOARD

BIOHOPE will hold an investigator meeting with their Scientific Advisory Board on the 23rd of September (4:00 p.m.) at the NH Hotel Hesperia de Barcelona, under the framework of the European Society of Organ Transplantation (ESOT) congress, to be held in Barcelona this year. The main objective of this meeting is to show and discuss [...]

2017-09-15T15:48:17+00:00September 12th, 2017|Collaborating Entities, Research|Comments Off on BIOHOPE WILL EXPLAIN THE PROMISING DATA FROM PILOT STUDY TO THEIR SCIENTIFIC ADVISORY BOARD

Biohope has initiated the first Clinical Trial in hospitals

Biohope, in collaboration with the Transplantation Units of “Puerta de Hierro” and “La Paz” University Hospitals (Madrid), has recently launched a Clinical Trial to evaluate its products in real clinical conditions. This is the first clinical study included in the Clinical Plan Program of Biohope in Renal Transplantation, and it is fully funded by the [...]

2017-02-10T11:24:47+00:00February 10th, 2017|Collaborating Entities, Research|Comments Off on Biohope has initiated the first Clinical Trial in hospitals

Biohope has been a finalist in several events worldwide for innovative startups in October

We have reason to be optimistic. Biohope has been a finalist in several events worldwide for innovative startups. First, Biohope was in South Summit (Madrid). Our project was selected as one of the top 10 health projects, selected from more than 3000 projects submitted. Biohope was also in SME Innovators Summit (Brussels), a competitive event [...]

2016-10-19T13:58:44+00:00October 18th, 2016|Recognitions and Awards, Research|Comments Off on Biohope has been a finalist in several events worldwide for innovative startups in October

BIOHOPE receives a significant Grant from the European Commission under Horizon 2020

BIOHOPE Scientific SL, the leading developer of Biotechnology diagnostic solutions to handle immunology of organ transplantation, is delighted to announce that it is to receive a grant in the latest round of Horizon 2020 SME Instrument Phase 2. The company will also benefit from 12 days of business coaching offered by the EC. The company [...]

2017-06-27T16:40:04+00:00July 6th, 2016|Research|Comments Off on BIOHOPE receives a significant Grant from the European Commission under Horizon 2020